Year: - Any -2023202220212020201920182017 Items per page 102550 Date Title Jan 11, 2021 Summary ToggleSol-Gel Technologies to Present at Upcoming 2021 Solebury Trout Virtual Investor Conference and H.C. Wainwright BioConnect Conference Dec 07, 2020 Summary ToggleSol-Gel Technologies Announces FDA Acceptance for Filing of New Drug Application for Twyneo® for the Treatment of Acne Vulgaris Nov 12, 2020 Summary ToggleSol-Gel Technologies Reports Third Quarter 2020 Financial Results and Corporate Update Nov 09, 2020 Summary ToggleSol-Gel to Present at Upcoming Healthcare Investor Conferences in November 2020 Nov 04, 2020 Summary ToggleSol-Gel Technologies to Report Third Quarter 2020 Financial Results on November 12, 2020 Sep 10, 2020 Summary ToggleSol-Gel Technologies Announces FDA Acceptance for Filing of New Drug Application for Epsolay® for the Treatment of Inflammatory Lesions of Rosacea Sep 08, 2020 Summary ToggleSol-Gel to Present at Upcoming Healthcare Investor Conferences in September Sep 03, 2020 Summary ToggleSol-Gel Technologies Collaboration Partner Filed First-to-File Paragraph IV Certification for Duobrii® Aug 06, 2020 Summary ToggleSol-Gel Technologies Reports Second Quarter 2020 Financial Results and Corporate Update Jul 29, 2020 Summary ToggleSol-Gel Technologies to Report Second Quarter 2020 Financial Results on August 6, 2020 Pagination First page First Previous page Previous … Page 3 Current page 4 Page 5 Page 6 … Next page Next Last page Last
Year: - Any -2023202220212020201920182017 Items per page 102550 Date Title Jan 11, 2021 Summary ToggleSol-Gel Technologies to Present at Upcoming 2021 Solebury Trout Virtual Investor Conference and H.C. Wainwright BioConnect Conference Dec 07, 2020 Summary ToggleSol-Gel Technologies Announces FDA Acceptance for Filing of New Drug Application for Twyneo® for the Treatment of Acne Vulgaris Nov 12, 2020 Summary ToggleSol-Gel Technologies Reports Third Quarter 2020 Financial Results and Corporate Update Nov 09, 2020 Summary ToggleSol-Gel to Present at Upcoming Healthcare Investor Conferences in November 2020 Nov 04, 2020 Summary ToggleSol-Gel Technologies to Report Third Quarter 2020 Financial Results on November 12, 2020 Sep 10, 2020 Summary ToggleSol-Gel Technologies Announces FDA Acceptance for Filing of New Drug Application for Epsolay® for the Treatment of Inflammatory Lesions of Rosacea Sep 08, 2020 Summary ToggleSol-Gel to Present at Upcoming Healthcare Investor Conferences in September Sep 03, 2020 Summary ToggleSol-Gel Technologies Collaboration Partner Filed First-to-File Paragraph IV Certification for Duobrii® Aug 06, 2020 Summary ToggleSol-Gel Technologies Reports Second Quarter 2020 Financial Results and Corporate Update Jul 29, 2020 Summary ToggleSol-Gel Technologies to Report Second Quarter 2020 Financial Results on August 6, 2020 Pagination First page First Previous page Previous … Page 3 Current page 4 Page 5 Page 6 … Next page Next Last page Last